Gene expression profiling of TGFβ2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-β2 signaling

Experimental Eye Research

Volumn 88, Issue 6, 2009, Pages 1020-1032

  Fuchshofer, Rudolf ^a   Stephan, Dietrich A ^b   Russell, Paul ^c   Tamm, Ernst R ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BMP7; extracellular matrix; Smad7; TGF 2; trabecular meshwork

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; OSTEOGENIC PROTEIN 1; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CAPZA1 GENE; CDC42BPB; EFEMP1 GENE; EXTRACELLULAR MATRIX; FGF5 GENE; FSTL3 GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HBEGF GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LTBP1 GENE; LTBP2 GENE; MATN2 GENE; NRP1 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERPINE GENE; SH2MD1 GENE; SIGNAL TRANSDUCTION; SMAD7 GENE; SMTN GENE; TFPI2 GENE; TNFAIP6 GENE; TRABECULAR MESHWORK; UNINDEXED SEQUENCE; VEGF GENE; WESTERN BLOTTING;

BONE MORPHOGENETIC PROTEIN 7; CELLS, CULTURED; CYTOKINES; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA2;

EID: 67349115359     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.01.002     Document Type: Article

References (94)

1. Acott T.S., and Kelley M.J. Extracellular matrix in the trabecular meshwork. Exp. Eye Res. 86 (2008) 543-561
2. Afrakhte M., Moren A., Jossan S., Itoh S., Sampath K., Westermark B., Heldin C.H., Heldin N.E., and ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem. Biophys. Res. Commun. 249 (1998) 505-511
3. Allerstorfer S., Sonvilla G., Fischer H., Spiegl-Kreinecker S., Gauglhofer C., Setinek U., Czech T., Marosi C., Buchroithner J., Pichler J., Silye R., Mohr T., Holzmann K., Grasl-Kraupp B., Marian B., Grusch M., Fischer J., Micksche M., and Berger W. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene 27 (2008) 4180-4190
4. Annes J.P., Chen Y., Munger J.S., and Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J. Cell Biol. 165 (2004) 723-734
5. Breen E.C. VEGF in biological control. J. Cell. Biochem. 102 (2007) 1358-1367
6. Chand H.S., Foster D.C., and Kisiel W. Structure, function and biology of tissue factor pathway inhibitor-2. Thromb. Haemost. 94 (2005) 1122-1130
7. Deak F., Wagener R., Kiss I., and Paulsson M. The matrilins: a novel family of oligomeric extracellular matrix proteins. Matrix Biol. 18 (1999) 55-64
8. Desmoulière A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122 (1993) 103-111
9. Dooley S., Hamzavi J., Ciuclan L., Godoy P., Ilkavets I., Ehnert S., Ueberham E., Gebhardt R., Kanzler S., Geier A., Breitkopf K., Weng H., and Mertens P.R. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135 (2008) 642-659
10. Dudley A.T., Lyons K.M., and Robertson E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9 (1995) 2795-2807
11. Eremina V., Baelde H.J., and Quaggin S.E. Role of the VEGF - a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron. Physiol. 106 (2007) 32-37
12. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., Gerber H.P., Kikkawa Y., Miner J.H., and Quaggin S.E. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111 (2003) 707-716
13. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13 (1992) 18-32
14. Ferrara N., Houck K.A., Jakeman L.B., Winer J., and Leung D.W. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47 (1991) 211-218
15. Fleenor D.L., Shepard A.R., Hellberg P.E., Jacobson N., Pang I.H., and Clark A.F. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Investig. Ophthalmol. Vis. Sci. 47 (2006) 226-234
16. Flügel-Koch C., Ohlmann A., Fuchshofer R., Welge-Lüssen U., and Tamm E.R. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Exp. Eye Res. 79 (2004) 649-663
17. Fuchshofer R., Welge-Lüssen U., and Lütjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp. Eye Res. 77 (2003) 757-765
18. Fuchshofer R., Yu A.H., Welge-Lüssen U., and Tamm E.R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 48 (2007) 715-726
19. Gamulescu M.A., Chen Y., He S., Spee C., Jin M., Ryan S.J., and Hinton D.R. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp. Eye Res. 83 (2006) 212-222
20. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish II R.K., Wilson M.R., and Kass M.A. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 714-720 [discussion: 829-830]
21. Gottanka J., Chan D., Eichhorn M., Lütjen-Drecoll E., and Ethier C.R. Effects of TGF-β2 in perfused human eyes. Investig. Ophthalmol. Vis. Sci. 45 (2004) 153-158
22. Hales A.M., Chamberlain C.G., and McAvoy J.W. Susceptibility to TGFbeta2-induced cataract increases with aging in the rat. Investig. Ophthalmol. Vis. Sci. 41 (2000) 3544-3551
23. Hann C.R., Springett M.J., Wang X., and Johnson D.H. Ultrastructural localization of collagen IV, fibronectin, and laminin in the trabecular meshwork of normal and glaucomatous eyes. Ophthalmic Res. 33 (2001) 314-324
24. Hebert J.M., Rosenquist T., Gotz J., and Martin G.R. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 78 (1994) 1017-1025
25. Higashiyama S., Lau K., Besner G.E., Abraham J.A., and Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267 (1992) 6205-6212
26. Hirai M., Horiguchi M., Ohbayashi T., Kita T., Chien K.R., and Nakamura T. Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. Embo J. 26 (2007) 3283-3295
27. Hirani R., Hanssen E., and Gibson M.A. LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. Matrix Biol. 26 (2007) 213-223
28. Hollborn M., Iandiev I., Seifert M., Schnurrbusch U.E., Wolf S., Wiedemann P., Bringmann A., and Kohen L. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr. Eye Res. 31 (2006) 863-874
29. Hollborn M., Tenckhoff S., Jahn K., Iandiev I., Biedermann B., Schnurrbusch U.E., Limb G.A., Reichenbach A., Wolf S., Wiedemann P., Kohen L., and Bringmann A. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol. Vis. 11 (2005) 397-413
30. Hou C.C., Wang W., Huang X.R., Fu P., Chen T.H., Sheikh-Hamad D., and Lan H.Y. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am. J. Pathol. 166 (2005) 761-771
31. Hughes R.A., Sendtner M., Goldfarb M., Lindholm D., and Thoenen H. Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons. Neuron 10 (1993) 369-377
32. Inatani M., Tanihara H., Katsuta H., Honjo M., Kido N., and Honda Y. Transforming growth factor-β2 levels in aqueous humor of glaucomatous eyes. Graefe's Arch. Clin. Exp. Ophthalmol. 239 (2001) 109-113
33. Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., Charbonneau N.L., Reinhardt D.P., Rifkin D.B., and Sakai L.Y. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J. Biol. Chem. 278 (2003) 2750-2757
34. Itoh S., and ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19 (2007) 176-184
35. Jamieson R.V., Perveen R., Kerr B., Carette M., Yardley J., Heon E., Wirth M.G., van Heyningen V., Donnai D., Munier F., and Black G.C. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum. Mol. Genet. 11 (2002) 33-42
36. Johnson M. 'What controls aqueous humour outflow resistance?. Exp. Eye Res. 82 (2006) 545-557
37. Ka S.M., Huang X.R., Lan H.Y., Tsai P.Y., Yang S.M., Shui H.A., and Chen A. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J. Am. Soc. Nephrol. 18 (2007) 1777-1788
38. Kamba T., Tam B.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., Norberg S.M., O'Brien S.M., Davis R.B., Gowen L.C., Anderson K.D., Thurston G., Joho S., Springer M.L., Kuo C.J., and McDonald D.M. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H560-H576
39. Kim J.I., Li T., Ho I.C., Grusby M.J., and Glimcher L.H. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 3781-3785
40. Kobayashi N., Kostka G., Garbe J.H., Keene D.R., Bachinger H.P., Hanisch F.G., Markova D., Tsuda T., Timpl R., Chu M.L., and Sasaki T. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J. Biol. Chem. 282 (2007) 11805-11816
41. Kuznetsova S.A., Day A.J., Mahoney D.J., Rugg M.S., Mosher D.F., and Roberts D.D. The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J. Biol. Chem. 280 (2005) 30899-30908
42. Kuznetsova S.A., Mahoney D.J., Martin-Manso G., Ali T., Nentwich H.A., Sipes J.M., Zeng B., Vogel T., Day A.J., and Roberts D.D. TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biol. 27 (2008) 201-210
43. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., and Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121 (2003) 48-56
44. Li J., Tripathi B.J., Chalam K.V., and Tripathi R.C. Transforming growth factor-beta 1 and -beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells. Investig. Ophthalmol. Vis. Sci. 37 (1996) 2778-2782
45. Li J., Tripathi B.J., and Tripathi R.C. Modulation of pre-mRNA splicing and protein production of fibronectin by TGF-β2 in porcine trabecular cells. Investig. Ophthalmol. Vis. Sci. 41 (2000) 3437-3443
46. Li J.H., Zhu H.J., Huang X.R., Lai K.N., Johnson R.J., and Lan H.Y. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J. Am. Soc. Nephrol. 13 (2002) 1464-1472
47. Lindholm D., Harikka J., da Penha Berzaghi M., Castren E., Tzimagiorgis G., Hughes R.A., and Thoenen H. Fibroblast growth factor-5 promotes differentiation of cultured rat septal cholinergic and raphe serotonergic neurons: comparison with the effects of neurotrophins. Eur. J. Neurosci. 6 (1994) 244-252
48. Luo G., Hofmann C., Bronckers A.L., Sohocki M., Bradley A., and Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9 (1995) 2808-2820
49. Lütjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog. Retin. Eye Res. 18 (1999) 91-119
50. Lütjen-Drecoll E., Rittig M., Rauterberg J., Jander R., and Mollenhauer J. Immunomicroscopical study of type VI collagen in the trabecular meshwork of normal and glaucomatous eyes. Exp. Eye Res. 48 (1989) 139-147
51. Lütjen-Drecoll E., Shimizu T., Rohrbach M., and Rohen J.W. Quantitative analysis of 'plaque material' in the inner and outer wall of Schlemm's canal in normal and glaucomatous eyes. Exp. Eye Res. 42 (1986) 443-455
52. Marmorstein L.Y., McLaughlin P.J., Peachey N.S., Sasaki T., and Marmorstein A.D. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 16 (2007) 2423-2432
53. Marmorstein L.Y., Munier F.L., Arsenijevic Y., Schorderet D.F., McLaughlin P.J., Chung D., Traboulsi E., and Marmorstein A.D. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13067-13072
54. Milner C.M., Higman V.A., and Day A.J. TSG-6: a pluripotent inflammatory mediator?. Biochem. Soc. Trans. 34 (2006) 446-450
55. Niessen P., Clement S., Fontao L., Chaponnier C., Teunissen B., Rensen S., van Eys G., and Gabbiani G. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp. Cell Res. 292 (2004) 170-178
56. Niessen P., Rensen S., van Deursen J., De Man J., De Laet A., Vanderwinden J.M., Wedel T., Baker D., Doevendans P., Hofker M., Gijbels M., and van Eys G. Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 129 (2005) 1592-1601
57. Ochiai Y., and Ochiai H. Higher concentration of transforming growth factor-β in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn. J. Ophthalmol. 46 (2002) 249-253
58. Park S.H. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J. Biochem. Mol. Biol. 38 (2005) 9-16
59. Picht G., Welge-Luessen U., Grehn F., and Lütjen-Drecoll E. Transforming growth factor-β2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefe's Arch. Clin. Exp. Ophthalmol. 239 (2001) 199-207
60. Quigley H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80 (1996) 389-393
61. Raab G., and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333 (1997) F179-F199
62. Ring B.Z., Cordes S.P., Overbeek P.A., and Barsh G.S. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development 127 (2000) 307-317
63. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108 Pt 6 (1995) 2369-2379
64. Rohen J.W., Lütjen-Drecoll E., Flügel C., Meyer M., and Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp. Eye Res. 56 (1993) 683-692
65. Ronnov-Jessen L., and Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor- beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68 (1993) 696-707
66. Saharinen J., Hyytiainen M., Taipale J., and Keski-Oja J. Latent transforming growth factor-β binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-β action. Cytokine Growth Factor Rev. 10 (1999) 99-117
67. Saika S., Yamanaka O., Nishikawa-Ishida I., Kitano A., Flanders K.C., Okada Y., Ohnishi Y., Nakajima Y., and Ikeda K. Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model. Arch. Ophthalmol. 125 (2007) 647-654
68. Schlötzer-Schrehardt U., Zenkel M., Küchle M., Sakai L.Y., and Naumann G.O. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp. Eye Res. 73 (2001) 765-780
69. Sidis Y., Mukherjee A., Keutmann H., Delbaere A., Sadatsuki M., and Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147 (2006) 3586-3597
70. Staton C.A., Kumar I., Reed M.W., and Brown N.J. Neuropilins in physiological and pathological angiogenesis. J. Pathol. 212 (2007) 237-248
71. Tamm E., Russell P., Epstein D.L., Johnson D.H., and Piatigorsky J. Modulation of Myocilin/TIGR expression in human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 40 (1999) 2577-2582
72. Tamm E.R., and Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma?. Surv. Ophthalmol. 52 Suppl. 2 (2007) S101-S104
73. Tamm E.R., Siegner A., Baur A., and Lütjen-Drecoll E. Transforming growth factor-β1 induces α-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp. Eye Res. 62 (1996) 389-397
74. Tamm E.R., Toris C.B., Crowston J.G., Sit A., Lim S., Lambrou G., and Alm A. Basic science of intraocular pressure. In: Weinreb R.N., Brandt J.D., Garway-Heath D., and Medeiros F. (Eds). Intraocular Pressure. Reports and Consensus Statements of the 4th Global AIGS Consensus Meeting on Intraocular Pressure (2007), Kugler Publications, Amsterdam 1-14
75. ten Dijke P., and Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29 (2004) 265-273
76. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130 (2000) 429-440
77. Thompson S.A., Higashiyama S., Wood K., Pollitt N.S., Damm D., McEnroe G., Garrick B., Ashton N., Lau K., Hancock N., et al. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J. Biol. Chem. 269 (1994) 2541-2549
78. Tripathi R.C., Li J., Chan W.F.A., and Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2. Exp. Eye Res. 58 (1994) 723-727
79. Tripathi R.C., Li J., Tripathi B.J., Chalam K.V., and Adamis A.P. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105 (1998) 232-237
80. Tsuchida K., Arai K.Y., Kuramoto Y., Yamakawa N., Hasegawa Y., and Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J. Biol. Chem. 275 (2000) 40788-40796
81. van Eys G.J., Niessen P.M., and Rensen S.S. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc. Med. 17 (2007) 26-30
82. Wagener R., Ehlen H.W., Ko Y.P., Kobbe B., Mann H.H., Sengle G., and Paulsson M. The matrilins-adaptor proteins in the extracellular matrix. FEBS Lett. 579 (2005) 3323-3329
83. Wear M.A., and Cooper J.A. Capping protein: new insights into mechanism and regulation. Trends Biochem. Sci. 29 (2004) 418-428
84. Welge-Lüssen U., May C.A., Eichhorn M., Bloemendal H., and Lütjen-Drecoll E. AlphaB-crystallin in the trabecular meshwork is inducible by transforming growth factor-beta. Investig. Ophthalmol. Vis. Sci. 40 (1999) 2235-2241
85. Welge-Lüssen U., May C.A., and Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF- β1 and TGF-β2. Investig. Ophthalmol. Vis. Sci. 41 (2000) 2229-2238
86. Wilkinson S., Paterson H.F., and Marshall C.J. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 7 (2005) 255-261
87. Wordinger R.J., Agarwal R., Talati M., Fuller J., Lambert W., and Clark A.F. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis. 8 (2002) 241-250
88. Wordinger R.J., Fleenor D.L., Hellberg P.E., Pang I.H., Tovar T.O., Zode G.S., Fuller J.A., and Clark A.F. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Investig. Ophthalmol. Vis. Sci. 48 (2007) 1191-1200
89. Wormstone I.M., Tamiya S., Anderson I., and Duncan G. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Investig. Ophthalmol. Vis. Sci. 43 (2002) 2301-2308
90. Xie H., Wang H., Tranguch S., Iwamoto R., Mekada E., Demayo F.J., Lydon J.P., Das S.K., and Dey S.K. Maternal heparin-binding-EGF deficiency limits pregnancy success in mice. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 18315-18320
91. You L., Kruse F.E., Pohl J., and Volcker H.E. Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Investig. Ophthalmol. Vis. Sci. 40 (1999) 296-311
92. Zhang S., Fei T., Zhang L., Zhang R., Chen F., Ning Y., Han Y., Feng X.H., Meng A., and Chen Y.G. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell Biol. 27 (2007) 4488-4499
93. Zhao X., Ramsey K.E., Stephan D.A., and Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Investig. Ophthalmol. Vis. Sci. 45 (2004) 4023-4034
94. Zhao X., and Russell P. Versican splice variants in human trabecular meshwork and ciliary muscle. Mol. Vis. 11 (2005) 603-608